We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
-16.35%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
AUM
$453M
AUM Growth
-$59.7M
Cap. Flow
+$29.7M
Cap. Flow %
6.57%
Top 10 Hldgs %
68.99%
Holding
1,172
New
669
Increased
301
Reduced
24
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 25.16%
2 Technology 5.29%
3 Energy 4.13%
4 Financials 3.62%
5 Consumer Discretionary 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STX icon
776
Seagate
STX
$192B
$5K ﹤0.01%
+66
New +$5.36K
SWK icon
777
Stanley Black & Decker
SWK
$15.1B
$5K ﹤0.01%
+44
New +$5.41K
TVTX icon
778
Travere Therapeutics
TVTX
$6.33B
$5K ﹤0.01%
+196
New +$4.93K
WRB icon
779
W.R. Berkley
WRB
$25.5B
$5K ﹤0.01%
+108
New +$4.91K
XPO icon
780
XPO
XPO
$22.5B
$5K ﹤0.01%
+158
New +$5.03K
XYL icon
781
Xylem
XYL
$26.5B
$5K ﹤0.01%
+68
New +$5.62K
CTXS
782
DELISTED
Citrix Systems Inc
CTXS
$5K ﹤0.01%
+49
New +$4.88K
SAIL
783
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$5K ﹤0.01%
+81
New +$5K
BHVN
784
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5K ﹤0.01%
+31
New +$3.96K
ACA icon
785
Arcosa
ACA
$7.13B
$4K ﹤0.01%
+83
New +$4.35K
AFRM icon
786
Affirm
AFRM
$25.6B
$4K ﹤0.01%
200
AMH icon
787
American Homes 4 Rent
AMH
$12.3B
$4K ﹤0.01%
+113
New +$4.28K
ANAB icon
788
AnaptysBio
ANAB
$1.72B
$4K ﹤0.01%
+176
New +$3.9K
ARMK icon
789
Aramark
ARMK
$15.7B
$4K ﹤0.01%
+191
New +$4.72K
ATR icon
790
AptarGroup
ATR
$8.6B
$4K ﹤0.01%
+40
New +$4.36K
OPTU
791
Optimum Communications Inc
OPTU
$412M
$4K ﹤0.01%
+429
New +$4.49K
BCS icon
792
Barclays
BCS
$91.1B
$4K ﹤0.01%
522
+14
+3% +$110
BEN icon
793
Franklin Templeton
BEN
$17.8B
$4K ﹤0.01%
+172
New +$4.4K
BIIB icon
794
Biogen
BIIB
$32.7B
$4K ﹤0.01%
+18
New +$3.68K
BIO icon
795
Bio-Rad Laboratories Class A
BIO
$10.4B
$4K ﹤0.01%
+8
New +$4.17K
BLNK icon
796
Blink Charging
BLNK
$85.9M
$4K ﹤0.01%
250
BMEA icon
797
Biomea Fusion
BMEA
$124M
$4K ﹤0.01%
+337
New +$1.97K
CAKE icon
798
Cheesecake Factory
CAKE
$5.74B
$4K ﹤0.01%
+160
New +$5.32K
CDW icon
799
CDW
CDW
$17.7B
$4K ﹤0.01%
+23
New +$3.87K
CFLT
800
DELISTED
Confluent
CFLT
$4K ﹤0.01%
+166
New +$4.47K

Similar funds

Crewe Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Crewe Advisors held 1,172 positions worth $453M, down 12% from $512M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Crewe Advisors deployed $29.7M of net new capital in Q2 2022, opening 669 new positions and adding to 301 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 19,385 shares worth $463K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Vanguard ESG US Stock ETF, an estimated $7.63M trimmed.

  • Crewe Advisors's largest Q2 2022 buy was iShares US Treasury Bond ETF: 19,385 shares worth $463K.
  • Crewe Advisors added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $4.1M increase.
  • Crewe Advisors's biggest Q2 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $7.63M.
  • Crewe Advisors fully exited Bank of Montreal in Q2 2022, selling an estimated $73K.
  • Crewe Advisors's ten largest holdings make up 69% of its $453M portfolio in Q2 2022.
  • Crewe Advisors opened 669 new positions and closed 6 in Q2 2022.
  • Crewe Advisors's portfolio value fell 12% quarter-over-quarter to $453M.

Based on Crewe Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.